Alkermes Announces Commercial Availability of LYBALVI® for the Treatment of Schizophrenia and Bipolar I Disorder - KKCO-TV

Submitted by Anonymous (not verified) on Mon, 10/18/2021 - 11:00

Alkermes Announces Commercial Availability of LYBALVI® for the Treatment of Schizophrenia and Bipolar I Disorder  KKCO-TV